Nuveen’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-68,490
Closed -$4.25M 3468
2021
Q3
$4.25M Sell
68,490
-4,104
-6% -$252K ﹤0.01% 2305
2021
Q2
$2.42M Sell
72,594
-12,614
-15% -$485K ﹤0.01% 2615
2021
Q1
$2.88M Sell
85,208
-1,351
-2% -$46.2K ﹤0.01% 2440
2020
Q4
$2.6M Buy
86,559
+5,093
+6% +$123K ﹤0.01% 2379
2020
Q3
$1.35M Sell
81,466
-2,329
-3% -$40.5K ﹤0.01% 2554
2020
Q2
$1.14M Sell
83,795
-36,848
-31% -$408K ﹤0.01% 2575
2020
Q1
$779K Sell
120,643
-2,208
-2% -$36.1K ﹤0.01% 2620
2019
Q4
$2.52M Buy
122,851
+4,631
+4% +$95.9K ﹤0.01% 2328
2019
Q3
$2.94M Sell
118,220
-3,342
-3% -$71.4K ﹤0.01% 2227
2019
Q2
$2.46M Buy
+121,562
New +$2.65M ﹤0.01% 2340

Nuveen's LDL Position: Q4 2021 in Review

Nuveen sold out of Lydall, Inc. (LDL) in Q4 2021, closing a stake of 68,490 shares — an estimated $4.25M sold.

Nuveen first reported a position in LDL in Q2 2019 and held it in 10 quarters. The position peaked at $4.25M in Q3 2021. 1 fund tracked by Wall St. Rank holds LDL as of Q4 2021.

  • Nuveen reported no remaining Lydall, Inc. position as of Q4 2021 after selling out during the quarter.
  • Nuveen sold 68,490 Lydall, Inc. shares in Q4 2021, an estimated $4.25M.
  • Nuveen first reported a position in Lydall, Inc. in Q2 2019 and held it in 10 quarters.
  • Nuveen's Lydall, Inc. position peaked at $4.25M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Lydall, Inc. as of Q4 2021.

Based on Nuveen's 13F filing for Q4 2021, filed 14 Feb 2022.